Clinical trials
1 active trial in India
Recruiting, about to start, or running now.
- The Causal Effects of Old Age Pensions NCT04029194
Updated
Reviewed by Vidhi Upadhyay
India Elderly Nutrition Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$621.4 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $486.5 Mn | — | — |
| 2025 (base) | $530.2 Mn | +$43.8 Mn | — |
| 2026 (forecast) | $578.0 Mn | +$47.7 Mn | +9% |
| 2027 (forecast) | $630.0 Mn | +$52.0 Mn | +18.8% |
| 2028 (forecast) | $686.7 Mn | +$56.7 Mn | +29.5% |
| 2029 (forecast) | $748.5 Mn | +$61.8 Mn | +41.2% |
| 2030 (forecast) | $815.9 Mn | +$67.4 Mn | +53.9% |
| 2031 (forecast) | $889.3 Mn | +$73.4 Mn | +67.7% |
| 2032 (forecast) | $969.3 Mn | +$80.0 Mn | +82.8% |
| 2033 (forecast) | $1.06 Bn | +$87.2 Mn | +99.3% |
| 2034 (forecast) | $1.15 Bn | +$95.1 Mn | +117.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $530.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.15 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, setting and distribution channel (see all) |
| Key players | Abbott Laboratories, Nestle, Danone Nutricia, Fresenius Kabi AG, Ajinomoto Co (see all) |
| Regulator in India | CDSCO and FSSAISource: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.Source: Food Safety and Standards Authority of India. Checked 14 Nov 2026. |
| Active clinical trials | 1 in IndiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Elderly nutrition products are foods and drinks designed for older adults, such as high-protein shakes, texture-modified meals and oral supplements.
Key segments of the elderly Nutrition Products market include product (Oral Nutritional Supplements, Texture-Modified Foods and Protein Fortified Foods) and setting (Home, Hospitals and Care Homes).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the elderly Nutrition Products market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the elderly Nutrition Products market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the elderly Nutrition Products market.
The elderly Nutrition Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.[1] Health supplements and nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI).[2] ClinicalTrials.gov lists 1 study on Elderly Nutrition Products that is recruiting, active or about to start in India.[3] People aged 65 and over: 7.4% of people in 2025, the latest World Bank figure for India.[4]
[1] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
[2] Food Safety and Standards Authority of India. Checked 14 Nov 2026.
[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in India. Retrieved 12 Nov 2026.
[4] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern elderly Nutrition Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in India.
What doctors and scientists are doing in Elderly Nutrition Products right now, from free public sources.
1 active trial in India
Recruiting, about to start, or running now.
7.4 % of people
People aged 65 and over, India, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
India
India
India
India
India
India
Public Health · India
Healthcare Services · India
Digital Health · India
Public Health · India
Pharmaceuticals · India
Medical Devices · India